Globus Medical — Third Quarter 2026 Earnings Summary

Globus Medical reported third-quarter 2026 worldwide net sales of $763.7 million, representing a 0.7% decrease from the prior year period. The company achieved GAAP net income of $141.2 million and non-GAAP diluted earnings per share of $1.23, reflecting an 18.2% and 4.4% increase respectively compared to the same quarter in 2025. Management updated its full-year 2026 revenue guidance to $3.09 billion while reaffirming non-GAAP diluted EPS guidance between $4.95 and $5.05. Additionally, the Board of Directors authorized a $500 million increase to the company's existing share repurchase program.